CLENZIDERM PORE THERAPY
- Product NDC
- 62032-110
- 11-digit product format
- 620320110
- Labeler code
- 62032
- Product ID
- 62032-110_1d93c707-3b66-4904-bc9c-deda90d26ab8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- SALICYLIC ACID
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- OMP, INC.
- Application
- part333D
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2007-02-01
- Marketing end
- 0000-00-00
- Substance
- SALICYLIC ACID
- Active strength
- 20 mg/mL
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 62032-110 | I | Inactivated by FDA | 2026-10-05 | ||
| excluded package | package | 62032-110 | 62032-110-60 | I | Inactivated by FDA | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 62032-110-60 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 62032-110-60 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 62032-110-60 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 62032-110-60 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 62032-110-60 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 62032-110-60 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 62032-110-60 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 62032-110-60 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 62032-110-60 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 62032-110-60 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 62032-110-60 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 62032-110-60 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 62032-110-60 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 62032-110-60 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 62032-110-60 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 62032-110-60 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 62032-110-60 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 62032-110-60 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 62032-110-60 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 62032-110-60 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 62032-110-60 | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 62032-110-60 | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62032-110-60 | 2019-11-13 | C162847 | 48780-1 | 97449f38-cf9e-f6ea-e053-dbdaa90aa703 | OBAGI ® CLENZIderm M.D.™ Pore Therapy |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-110-60 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 mL | 20 mg in 1mL | 1 |
| 62032-110-60 | CLENZIDERM PORE THERAPY ACNE TREATMENT | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 | 1 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-110 | CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.] | 1 | Legacy NDC | 20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip |
| 62032-110 | CLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) LIQUID [OMP, INC.] | 1 | Legacy NDC, 1 package rows | 20111221_852f01d0-5859-4482-a1fa-91827c964001.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 106309 | benzoyl peroxide 5 % Topical Lotion | PSN | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1236624 | Clenziderm Lotion 5 % Topical Lotion | PSN | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235205 | CLENZIderm M.D. 2 % Medicated Liquid Soap | PSN | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 562600 | salicylic acid 2 % Medicated Liquid Soap | PSN | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1236624 | benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion] | SBD | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235205 | salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm] | SBD | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 106309 | benzoyl peroxide 50 MG/ML Topical Lotion | SCD | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 562600 | salicylic acid 20 MG/ML Medicated Liquid Soap | SCD | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 106309 | benzoyl peroxide 5 % Topical Lotion | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235205 | Clenziderm 20 MG/ML Medicated Liquid Soap | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 1236624 | Clenziderm Lotion 5 % Topical Lotion | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1236624 | Clenziderm Lotion 50 MG/ML Topical Lotion | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235205 | Clenziderm M.D. 2 % Daily Care Cleanser | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 562600 | salicylic acid 2 % Facial Cleanser Toner | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 562600 | salicylic acid 2 % Facial Scrub | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 562600 | salicylic acid 2 % Medicated Liquid Soap | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 852f01d0-5859-4482-a1fa-91827c964001 | 1 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 934ec314-1ab7-45ee-a2fe-8bff3ff981b6 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Status |
|---|---|---|---|---|
| 62032-110-60 | 62032011060 | 118 mL in 1 BOTTLE, PLASTIC | 118 ml | Historical |